Biotech pared earlier declines and advanced to session highs Tuesday afternoon ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Xtandi Congressional Letter and CFO Change a Modest Negative at Worst for Medivation (MDVN) - UBS March 29, 2016 8:38 AM Members of Congress Ask NIH and HHS to Examine Xtandi Pricing (MDVN) - CNBC March 28, 2016 4:41 PM